Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2025年2月26-28日
日本京都, Westin Miyako Kyoto

主会议 第3天

主会议 第3天

8:00am - 8:10am10分钟
Registration and Coffee
报到・咖啡时光
    Plenary Session
    主题讲演单元
    8:10am - 8:15am5分钟
    Plenary Sessions
    主题讲演单元
    Chairperson’s Remarks: Plenary Day 3
    主席致辞：主题讲演（第3天）
      8:15am - 8:45am30分钟
      Plenary Sessions
      主题讲演单元
      Lipid Nanoparticles for mRNA Vaccine Delivery
      用于 mRNA 疫苗递送的脂质纳米颗粒
      • Mate Vadovics, PhD - Postdoctoral Fellow, Norbert Pardi Lab, University of Pennsylvania
      8:45am - 9:15am30分钟
      Plenary Sessions
      主题讲演单元
      LEAD (Ligand- and Enhancer-Assisted Delivery) Enables Efficient siRNA Delivery to Immune Cells by Targeting a Cell Type-Specific Receptors
      LEAD（配体和增强剂辅助递送）透过靶向细胞类型特异性受体，实现将 siRNA 高效递送至免疫细胞
      • Weimin Wang, PhD - Founder & CEO, Sanegene Bio
      9:15am - 9:45am30分钟
      Plenary Sessions
      主题讲演单元
      Phase 1 Clinical Testing of a First-in-Class ASO Therapeutic against Metastatic Cancer
      治疗转移性癌症的 first-in-class ASO 疗法的 I 期临床试验
      • Zdravka Medarova, PhD - Co-Founder and Chief Scientific Officer, TransCode Therapeutics
      9:45am - 10:15am30分钟
      Plenary Sessions
      主题讲演单元
      Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS System for ASO
      使用新型 ASO DDS 系统标靶 lncRNA TUG1 治疗 GBM 患者
      • Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
      10:15am - 10:55am40分钟
      Networking Refreshment Break with Poster and Exhibit Viewing
      上午互动交流休息时间，观赏海报和展览
        Concurrent Conference Tracks
        同时进行的各个分会
        10:55am - 11:00am5分钟
        Track #1: Oligonucleotides
        分会1：寡核苷酸
        Chairperson’s Remarks: Track 1
        主席致辞：分会1
          10:55am - 11:00am5分钟
          Track #2: Peptides
          分会2：胜肽
          Chairperson’s Remarks: Track 2
          主席致辞：分会2
            11:00am - 11:30am30分钟
            Track #1: Oligonucleotides
            分会1：寡核苷酸
            Probing Chemical Space to Improve siRNA Therapeutic Profile
            研究化学空间以改善 siRNA 的治疗效果
            • Mehran Nikan, PhD - Research Fellow, Ionis Pharmaceuticals
            11:00am - 11:30am30分钟
            Track #2: Peptides
            分会2：胜肽
            Revolutionizing Healthcare: Pioneering Peptide Innovations by AI Computational Design
            改变医疗保健：透过人工智慧运算设计引领胜肽创新
            • Kerry Blanchard, MD, PhD - CEO, Chairman and Founder, Perpetual Medicines
            11:30am - 12:00pm30分钟
            Track #1: Oligonucleotides
            分会1：寡核苷酸
            Development of Targeted RNA Therapeutics: Preclinical, Clinical Progress and Lessons Learned
            靶向 RNA 疗法的开发：临床前和临床试验的进展和经验教训
            • Hanhua Huang, PhD - Vice President, Biology, Avidity Biosciences
            11:30am - 12:00pm30分钟
            Track #2: Peptides
            分会2：胜肽
            Identification of Disulfide Constrained Peptide Based Binders against Membrane Bound E3 Ubiquitin Ligases
            鉴定细胞膜结合的 E3 泛素连接酶的二硫键限制性肽结合物
            • Xinxin Gao, PhD - Principal Scientific Manager, Peptide Therapeutics, Genentech
            12:00pm - 12:30pm30分钟
            Track #1: Oligonucleotides
            分会1：寡核苷酸
            Advancing Oligonucleotide and Gene Editing: Enhanced Capabilities Through Synergy
            寡核苷酸和基因编辑的进步：通过协同作用增强功能
            • Blake Unterreiner - Associate VP, Business Development & Customer Relations, NASD, Agilent Technologies
            12:00pm - 12:30pm30分钟
            Track #2: Peptides
            分会2：胜肽
            First De-novo Designed Cyclic Peptides for SORT1 and CNS Delivery
            首个用于 SORT1 和 CNS 递送的从头设计的环肽
            • Lucas Siow - CEO and Co-Founder, ProteinQure
            12:30pm - 1:40pm70分钟
            Networking Luncheon with Poster and Exhibit Viewing
            休憩时间・午餐会，观赏海报和展览
              1:40pm - 1:45pm5分钟
              Track #1: Oligonucleotides
              分会1：寡核苷酸
              Chairperson’s Remarks: Track 1
              主席致辞：分会1
                1:40pm - 1:45pm5分钟
                Track #2: Peptides
                分会2：胜肽
                Chairperson’s Remarks: Track 2
                主席致辞：分会2
                  1:45pm - 2:15pm30分钟
                  Track #1: Oligonucleotides
                  分会1：寡核苷酸
                  Design and Selection of High-Affinity XenoAptamers for Diagnostic and Therapeutic Applications
                  用于诊断和治疗的高亲和力异适配体的设计与选择
                  • Michiko Kimoto, PhD - Chief Operating Officer, R&D Director, Xenolis Pte. Ltd.
                  1:45pm - 2:15pm30分钟
                  Track #2: Peptides
                  分会2：胜肽
                  Program Update on JNJ-2113, The First and Only Investigational Targeted Oral Peptide for Psoriasis
                  JNJ-2113计划最新进展：第一个也是唯一一个进入临床试验的银屑病标靶口服胜肽
                  • Steven Fakharzadeh, MD, PhD - Global Medical Affairs Leader Immunodermatology, Janssen
                  2:15pm - 2:45pm30分钟
                  Track #1: Oligonucleotides
                  分会1：寡核苷酸
                  Nitto Bispecific siRNA Targeting YAP1/WWTR1 As A Novel Therapeutic Agent for Liver Fibrosis
                  作为肝纤维化新型治疗剂的日东电工的 YAP1/WWTR1 标靶双特异性 siRNA
                  • Masayuki Sugimoto, PhD - Manager, Nitto Denko Corporation
                  2:15pm - 2:45pm30分钟
                  Track #2: Peptides
                  分会2：胜肽
                  Oral Peptide Therapeutics for Gut Disorders
                  治疗肠道疾病的口服肽
                  • Markus Muttenthaler, PhD - Associate Professor, Neuropeptide Research, The University of Queensland and University of Vienna
                  2:45pm - 3:15pm30分钟
                  Track #1: Oligonucleotides
                  分会1：寡核苷酸
                  Recent Progress of Luxna’s Antisense Oligonucleotide Therapeutics Platform and Application to Neurological Diseases
                  Luxna的反义寡核苷酸治疗平台及其在神经系统疾病中的应用：最新研究成果
                  • Hideaki Sato - President and CEO, Luxna Biotech
                  2:45pm - 3:15pm30分钟
                  Track #2: Peptides
                  分会2：胜肽
                  Biodegradable Silica Composite Technology Enabling Long-Acting Controlled Release of GLP-1RAs
                  利用可生物降解二氧化矽复合技术实现GLP-1RA长效控释
                  • Lasse Leino, PhD - Chief Executive Officer, Adjunct Professor, DelSiTech Ltd.
                  3:15pm - 3:45pm30分钟
                  Networking Refreshment Break with Poster and Exhibit Viewing
                  互动交流休息时间，观赏海报和展览
                    3:45pm - 4:15pm30分钟
                    Track #1: Oligonucleotides
                    分会1：寡核苷酸
                    Reviving ANGPTL4 As a Drug Target with a GalNAc ASO Approach - A Case Study
                    使用 GalNAc ASO 方法恢复 ANGPTL4 作为药物标靶：案例研究
                    • Stefan Nilsson, Ph.D. - CEO, Lipigon Pharmaceuticals AB
                    3:45pm - 4:15pm30分钟
                    Track #2: Peptides
                    分会2：胜肽
                    Discovery of Macrocyclic Peptide Inhibitors of SIRT7 and HDAC11
                    SIRT7 和 HDAC11 大环肽抑制剂的发现
                    • Christian Adam Olsen, PhD - Professor, Drug Design and Pharmacology, University of Copenhagen
                    4:15pm - 4:45pm30分钟
                    Track #1: Oligonucleotides
                    分会1：寡核苷酸
                    Recent Progress in the Treatment of Myotonic Dystrophy Type 1 (DM1), The Most Common Adult-onset Muscular Dystrophy
                    1 型强直性肌肉营养不良症 (DM1)最常见的成人发病性肌肉营养不良症治疗的最新进展
                    • Frederic Legros, PhD - CEO, ARTHEx Biotech
                    4:15pm - 4:45pm30分钟
                    Track #2: Peptides
                    分会2：胜肽
                    Preclinical Studies of Macrocyclic Peptides, Targeted Radiopharmaceutical Agents for PDL-1, Developed with 48Hour Discovery Pipeline
                    透过48 小时药物发现管道开发的大环肽、PDL-1 靶向放射性药物的临床前研究
                    • Ratmir Derda, PhD - Founder and CSO, 48 Hour Discovery, University of Alberta
                    4:45pm - 5:15pm30分钟
                    Track #1: Oligonucleotides
                    分会1：寡核苷酸
                    The Use of Oligonucleotides in the Treatment of Neurodegenerative Disorders
                    寡核苷酸在神经退化性疾病治疗的应用
                    • Michael Gold, MD - Chief R&D Officer, Compass Pathways
                    4:45pm - 5:15pm30分钟
                    Track #2: Peptides
                    分会2：胜肽
                    Combining Advanced Peptide Screening Methods to Identify Macrocyclic Peptide Candidates for Radiotherapy Development
                    结合先进的胜肽筛选方法来鉴定用于放射治疗开发的大环肽候选物
                    • Weiliang Xu, PhD - Associate Director of Business Development, PepLib
                    5:15pm - 5:20pm5分钟
                    Close of Conference
                    会议结束
                      主会议 第2天

                      * 活动内容有可能不事先告知作更动及调整。